ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Scope & Guideline

Catalyzing Change in Liver and Digestive Health

Introduction

Explore the comprehensive scope of ALIMENTARY PHARMACOLOGY & THERAPEUTICS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ALIMENTARY PHARMACOLOGY & THERAPEUTICS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0269-2813
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1987 to 2024
AbbreviationALIMENT PHARM THER / Aliment. Pharmacol. Ther.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

Alimentary Pharmacology & Therapeutics (AP&T) is dedicated to publishing high-quality research in the fields of gastroenterology and hepatology, with a strong emphasis on the pharmacological aspects of digestive diseases. The journal's focus encompasses a broad range of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver disorders, integrating clinical studies, basic research, and innovative therapeutic strategies.
  1. Gastrointestinal and Liver Disease Research:
    The journal covers a wide array of gastrointestinal and liver diseases, highlighting research on pathophysiology, diagnosis, and treatment options.
  2. Pharmacotherapy and Treatment Strategies:
    AP&T emphasizes the role of pharmacotherapy in managing gastrointestinal and liver diseases, including studies on drug efficacy, safety, and guidelines for clinical practice.
  3. Emerging Therapies and Interventions:
    The journal frequently publishes research on novel treatment modalities, including biologics, small molecules, and innovative therapies for various digestive disorders.
  4. Clinical Guidelines and Best Practices:
    AP&T aims to provide evidence-based recommendations for clinicians, focusing on improving patient outcomes in gastrointestinal and liver diseases.
  5. Patient-Centered Outcomes and Quality of Life:
    The journal addresses the importance of patient-reported outcomes, quality of life, and the psychosocial aspects of managing chronic digestive diseases.
  6. Epidemiological Studies and Public Health:
    Research related to the epidemiology of gastrointestinal and liver diseases, including risk factors, prevalence, and the impact of public health initiatives, is a key focus area.
  7. Technology and Innovation in Gastroenterology:
    AP&T explores advancements in diagnostic and therapeutic technologies, including the use of machine learning and non-invasive testing methods in gastroenterology.
The landscape of research within Alimentary Pharmacology & Therapeutics is evolving, with several emerging themes gaining traction in recent publications. This section outlines these trending topics that reflect the current interests and priorities in the fields of gastroenterology and hepatology.
  1. Metabolic Dysfunction-Associated Liver Disease (MAFLD):
    Research on MAFLD is increasingly prominent, focusing on its clinical implications, pathophysiology, and treatment strategies, reflecting a growing recognition of its significance.
  2. Biologics and Targeted Therapies:
    The use of biologics and targeted therapies for inflammatory bowel disease (IBD) and other gastrointestinal conditions is a rapidly expanding area of research, with a focus on optimizing treatment regimens.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning in predicting disease outcomes and personalizing treatment approaches is a growing trend, indicating a shift towards data-driven medicine.
  4. Patient-Centered Care and Quality of Life:
    There is an increasing emphasis on research that evaluates patient-reported outcomes and quality of life in the context of gastrointestinal diseases, aligning with broader trends in healthcare.
  5. Public Health and Epidemiology:
    Studies addressing the epidemiology of liver diseases and gastrointestinal disorders, as well as public health interventions, are gaining traction, reflecting an awareness of the societal impact of these conditions.
  6. Gut Microbiome Research:
    The exploration of the gut microbiome’s role in health and disease, particularly in IBD and liver diseases, is an emerging theme, highlighting its significance in therapeutic strategies.
  7. Long-term Outcomes of Chronic Diseases:
    Research focusing on the long-term outcomes of chronic gastrointestinal and liver diseases, including the impact of treatment on disease progression and survival, is becoming increasingly important.

Declining or Waning

While Alimentary Pharmacology & Therapeutics continues to thrive in many areas, certain themes appear to be declining in prominence based on recent publication trends. This section highlights those waning topics, indicating shifts in research focus within the journal.
  1. Traditional Dietary Interventions:
    Research focusing solely on traditional dietary interventions for gastrointestinal diseases has seen reduced emphasis, as newer therapies and pharmacological approaches gain prominence.
  2. Basic Science without Clinical Relevance:
    Studies that do not translate into clinical applications or lack direct relevance to patient care are being published less frequently, as the journal prioritizes clinically impactful research.
  3. Single-Center Studies:
    There is a noticeable decline in the publication of single-center studies, with a shift towards multi-center and larger cohort studies that yield more generalizable results.
  4. Isolated Pathophysiological Mechanisms:
    Research focusing solely on isolated mechanisms of disease without exploring therapeutic implications or clinical outcomes is diminishing, reflecting a preference for integrated approaches.
  5. Non-Pharmacological Treatments:
    There appears to be a waning interest in non-pharmacological treatments for digestive diseases, as the journal increasingly emphasizes pharmacotherapy and innovative drug treatments.

Similar Journals

JOURNAL OF NEPHROLOGY

Transforming kidney health through academic excellence.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Empowering clinicians with essential knowledge in pediatric nutrition.
Publisher: WILEYISSN: 0277-2116Frequency: 12 issues/year

Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.

Gastroenterology Research and Practice

Empowering Healthcare with Open Access Knowledge
Publisher: HINDAWI LTDISSN: 1687-6121Frequency:

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

Korean Journal of Gastroenterology

Your Gateway to Gastrointestinal Research and Innovation
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Gastroenterology Review-Przeglad Gastroenterologiczny

Fostering Dialogue and Discovery in Digestive Disorders
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1895-5770Frequency: 4 issues/year

Gastroenterology Review-Przeglad Gastroenterologiczny is a premier, peer-reviewed journal published by TERMEDIA PUBLISHING HOUSE LTD, focusing on the dynamic field of gastroenterology. Since its inception in 2006, it has embraced an Open Access model, ensuring that the latest research is readily accessible to a global audience, fostering collaboration and innovation. Based in Poland, this journal serves as a crucial platform for disseminating significant findings in gastrointestinal research, with a current Scopus rank placing it at the 39th percentile in its category. With a commitment to advancing the understanding of gastroenterological conditions, *Gastroenterology Review* publishes original articles, reviews, and case studies that contribute to both clinical practice and academic research. The journal is particularly aimed at researchers, healthcare professionals, and students who ignite dialogues that shape the future of gastrointestinal health. Explore the comprehensive insights that this journal offers, as it encapsulates vital developments from 2008 to 2024 in the ever-evolving landscape of gastroenterology.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Advancing knowledge in digestive health.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0954-691XFrequency: 12 issues/year

The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.

Gastroenterology

Connecting Research to Practice in Gastroenterology
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0016-5085Frequency: 12 issues/year

Gastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.

Hepatology International

Connecting experts to revolutionize liver health.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

Pediatric Gastroenterology Hepatology & Nutrition

Transforming knowledge into practice for healthier futures.
Publisher: KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITIONISSN: 2234-8646Frequency: 6 issues/year

Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.

Gastrointestinal Disorders

Transforming Gastroenterology Through Collaborative Scholarship
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.